D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emerson Electric
EMR
|
+$546M |
| 2 |
Amazon
AMZN
|
+$515M |
| 3 |
Tesla
TSLA
|
+$389M |
| 4 |
Netflix
NFLX
|
+$322M |
| 5 |
Adobe
ADBE
|
+$305M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$836M |
| 2 |
CELG
Celgene Corp
CELG
|
+$460M |
| 3 |
NVIDIA
NVDA
|
+$429M |
| 4 |
ConocoPhillips
COP
|
+$311M |
| 5 |
Biogen
BIIB
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.23% |
| 2 | Consumer Discretionary | 11.75% |
| 3 | Healthcare | 9.92% |
| 4 | Financials | 7.86% |
| 5 | Industrials | 6.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
VICI Properties
VICI
$29.4B
| $87.7M | 0.1% |
3,431,457
+1,918,547
| +127% | +$46.4M |
|
227
PUT
Cisco
CSCO
$450B
| $87.6M | 0.1% |
1,826,800
+1,001,900
| +121% | +$46.6M |
|
228
CALL
Chevron
CVX
$388B
| $87.3M | 0.1% |
724,300
+343,100
| +90% | +$40.4M |
|
229
Morgan Stanley
MS
$337B
| $87.1M | 0.1% |
1,703,830
-3,168,174
| -65% | -$150M |
|
230
Cardinal Health
CAH
$53.4B
| $87.1M | 0.1% |
1,721,496
-14,294
| -0.8% | -$738K |
|
231
F5
FFIV
$22.1B
| $86.3M | 0.1% |
617,956
+117,068
| +23% | +$16.5M |
|
232
Textron
TXT
$16.6B
| $85.6M | 0.1% |
1,919,127
+542,704
| +39% | +$25.1M |
|
233
Hartford Financial Services
HIG
$38.5B
| $85.4M | 0.1% |
1,405,408
-414,552
| -23% | -$24.9M |
|
234
Pediatrix Medical
MD
$2.16B
| $85.1M | 0.1% |
3,060,653
-522,728
| -15% | -$13.1M |
|
235
United Therapeutics
UTHR
$26.3B
| $84.5M | 0.1% |
959,171
+45,115
| +5% | +$3.97M |
|
236
State Street
STT
$50.9B
| $84.4M | 0.1% |
1,067,464
-2,340,903
| -69% | -$165M |
|
237
Atlassian
TEAM
$22B
| $84.4M | 0.1% |
701,201
-447,883
| -39% | -$54.5M |
|
|
PLAN
238
DELISTED
Anaplan, Inc.
PLAN
| $84.3M | 0.1% |
1,609,310
+921,148
| +134% | +$45.7M |
|
239
PUT
Western Digital
WDC
$179B
| $84.3M | 0.1% |
1,756,679
+223,190
| +15% | +$9.31M |
|
240
CALL
Procter & Gamble
PG
$343B
| $84.1M | 0.1% |
673,500
-73,300
| -10% | -$8.97M |
|
241
BlackLine
BL
$1.69B
| $84.1M | 0.1% |
1,630,611
+246,792
| +18% | +$12.3M |
|
242
Fortive
FTV
$19B
| $83.6M | 0.1% |
1,735,352
+207,870
| +14% | +$9.39M |
|
243
CALL
Goldman Sachs
GS
$313B
| $83.6M | 0.1% |
363,400
-12,900
| -3% | -$2.8M |
|
244
Cadence Design Systems
CDNS
$90B
| $82.8M | 0.09% |
1,193,739
+434,726
| +57% | +$29.2M |
|
|
245
CALL
Alibaba
BABA
$269B
| $82.7M | 0.09% |
390,000
+58,400
| +18% | +$11M |
|
246
Sempra
SRE
$60.8B
| $82.6M | 0.09% |
1,091,078
-217,582
| -17% | -$16M |
|
247
CALL
UnitedHealth
UNH
$382B
| $82.5M | 0.09% |
280,500
+121,700
| +77% | +$31.8M |
|
248
CALL
Salesforce
CRM
$134B
| $82.3M | 0.09% |
506,070
+83,700
| +20% | +$13.1M |
|
|
249
CALL
Morgan Stanley
MS
$337B
| $82M | 0.09% |
1,603,600
+115,700
| +8% | +$5.48M |
|
250
Vertex Pharmaceuticals
VRTX
$121B
| $81.9M | 0.09% |
373,973
-324,695
| -46% | -$65.7M |
|
Similar funds
D.E. Shaw & Co's Q4 2019 Portfolio in Review
As of Q4 2019, D.E. Shaw & Co held 4,337 positions worth $87.5B, up 7.7% from $81.2B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
D.E. Shaw & Co's Q4 2019 filing shows 572 new, 1,477 increased, 1,498 reduced and 412 closed positions. Its largest new stake was Tesla: 17,953,230 shares worth $501M. The largest sale was Alibaba, an estimated $836M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- D.E. Shaw & Co's largest Q4 2019 buy was Tesla: 17,953,230 shares worth $501M.
- D.E. Shaw & Co added most to Emerson Electric in Q4 2019, an estimated $546M increase.
- D.E. Shaw & Co's biggest Q4 2019 reduction was Alibaba, cutting an estimated $836M.
- D.E. Shaw & Co fully exited Celgene Corp in Q4 2019, selling an estimated $460M.
- D.E. Shaw & Co's ten largest holdings make up 10% of its $87.5B portfolio in Q4 2019.
- D.E. Shaw & Co opened 572 new positions and closed 412 in Q4 2019.
- D.E. Shaw & Co's portfolio value rose 7.7% quarter-over-quarter to $87.5B.
Based on D.E. Shaw & Co's 13F filing for Q4 2019, filed 14 Feb 2020.